LOGIN
Aspirin vs Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis after TKA
March 2024
Aspirin vs Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis after TKA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Int J Surg . 2023 Nov 1;109(11):3648-3655.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
In this systematic review and meta-analysis, six studies of 6772 patients who received prophylactic anticoagulant therapy after total knee arthroplasty (TKA) were analysed to compare aspirin versus low-molecular-weight heparin (LMWH). Pooled outcomes of interest included the incidence of VTE, deep venous thrombosis (DVT), pulmonary embolism (PE), as well as bleeding complications rates. The pooled...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.